Neoplastic meningitis epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
(Mahshid)
 
(3 intermediate revisions by 2 users not shown)
Line 4: Line 4:


==Overview==
==Overview==
Neoplastic meningitis occurs in approximately 3-5% of patients with solid tumor, 5-15% of patients with leukemia, and 1-2% of patients with primary brain tumors.<ref name="GleissnerChamberlain2006">{{cite journal|last1=Gleissner|first1=Beate|last2=Chamberlain|first2=Marc Charles|title=Neoplastic meningitis|journal=The Lancet Neurology|volume=5|issue=5|year=2006|pages=443–452|issn=14744422|doi=10.1016/S1474-4422(06)70443-4}}</ref><ref name=epidemiologynm2>Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016</ref>
Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with [[solid tumors]], 5000-15,000 of 100,000 patients with [[leukemia]], and 1000-2000 of 100,000 patients with primary [[brain tumors]].<ref name="GleissnerChamberlain2006">{{cite journal|last1=Gleissner|first1=Beate|last2=Chamberlain|first2=Marc Charles|title=Neoplastic meningitis|journal=The Lancet Neurology|volume=5|issue=5|year=2006|pages=443–452|issn=14744422|doi=10.1016/S1474-4422(06)70443-4}}</ref><ref name="epidemiologynm2">Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016</ref>


==Epidemiology and Demographics==
==Epidemiology and Demographics==
===Prevalence===
===Incidence===
Neoplastic meningitis occurs in approximately 3-5% of patients with solid tumor, 5-15% of patients with leukemia, and 1-2% of patients with primary brain tumors.<ref name="GleissnerChamberlain2006">{{cite journal|last1=Gleissner|first1=Beate|last2=Chamberlain|first2=Marc Charles|title=Neoplastic meningitis|journal=The Lancet Neurology|volume=5|issue=5|year=2006|pages=443–452|issn=14744422|doi=10.1016/S1474-4422(06)70443-4}}</ref><ref name=epidemiologynm2>Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016</ref>
 
* Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with [[solid tumors]].
*Neoplastic meningitis occurs in approximately 5000-15,000 of 100,000 patients with [[leukemia]].
*Neoplastic meningitis occurs in approximately 1000-2000 of 100,000 patients with primary [[brain tumors]].<ref name="GleissnerChamberlain2006">{{cite journal|last1=Gleissner|first1=Beate|last2=Chamberlain|first2=Marc Charles|title=Neoplastic meningitis|journal=The Lancet Neurology|volume=5|issue=5|year=2006|pages=443–452|issn=14744422|doi=10.1016/S1474-4422(06)70443-4}}</ref><ref name="epidemiologynm2">Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016</ref>
 
=== Prevalence ===
 
* Observational studies show that neoplastic meningitis develop in 1-5% of solid tumors, of which [[adenocarcinoma]] is the most frequently observed histology.
* Neoplastic meningitis typically develop in the setting of an advanced stage and widely disseminated cancer in 70% of the cases. It can also present during the patients disease-free interval or remission in 20% of the time, and even be the first manifestation of cancer (5-10%) occasionally.<ref>{{Cite web|url=http://theoncologist.alphamedpress.org/content/13/9/967.full|title=Neoplastic Meningitis|last=|first=|date=|website=|archive-url=|archive-date=|dead-url=|access-date=}}</ref>
 
=== Age ===
 
* Neoplastic meningitis occurs more in elderly people, as it is associated with other primary cancer development.


==References==
==References==

Latest revision as of 15:31, 16 August 2019

Neoplastic meningitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Neoplastic Meningitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Neoplastic meningitis epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Neoplastic meningitis epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Neoplastic meningitis epidemiology and demographics

CDC on Neoplastic meningitis epidemiology and demographics

Neoplastic meningitis epidemiology and demographics in the news

Blogs on Neoplastic meningitis epidemiology and demographics

Directions to Hospitals Treating Choroid plexus papilloma

Risk calculators and risk factors for Neoplastic meningitis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Sujit Routray, M.D. [2]

Overview

Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with solid tumors, 5000-15,000 of 100,000 patients with leukemia, and 1000-2000 of 100,000 patients with primary brain tumors.[1][2]

Epidemiology and Demographics

Incidence

  • Neoplastic meningitis occurs in approximately 3000-5000 of 100,000 patients with solid tumors.
  • Neoplastic meningitis occurs in approximately 5000-15,000 of 100,000 patients with leukemia.
  • Neoplastic meningitis occurs in approximately 1000-2000 of 100,000 patients with primary brain tumors.[1][2]

Prevalence

  • Observational studies show that neoplastic meningitis develop in 1-5% of solid tumors, of which adenocarcinoma is the most frequently observed histology.
  • Neoplastic meningitis typically develop in the setting of an advanced stage and widely disseminated cancer in 70% of the cases. It can also present during the patients disease-free interval or remission in 20% of the time, and even be the first manifestation of cancer (5-10%) occasionally.[3]

Age

  • Neoplastic meningitis occurs more in elderly people, as it is associated with other primary cancer development.

References

  1. ↑ 1.0 1.1 Gleissner, Beate; Chamberlain, Marc Charles (2006). "Neoplastic meningitis". The Lancet Neurology. 5 (5): 443–452. doi:10.1016/S1474-4422(06)70443-4. ISSN 1474-4422.
  2. ↑ 2.0 2.1 Hayat, M. A. Brain metastases from primary tumors : epidemiology, biology, and therapy. London: Elsevier/Academic Press, 2014. Print.| url=https://books.google.com/books?id=IloXAwAAQBAJ&pg=PA43&lpg=PA43&dq=leptomeningeal+carcinomatosis+is+present+in+1-5%25+of+patients+with+solid+tumors,+5-15%25+of+patients+with+leukemia,+and+1-2%25+of+patients+with+primary+brain+tumors.&source=bl&ots=ehEaDBCT5f&sig=vvSxdxDjNMBe0CdCP6fEcMaYJqU&hl=en&sa=X&ved=0ahUKEwi2ueuw37bKAhUG8j4KHWUUCoIQ6AEILTAC#v=onepage&q=leptomeningeal%20carcinomatosis%20is%20present%20in%201-5%25%20of%20patients%20with%20solid%20tumors%2C%205-15%25%20of%20patients%20with%20leukemia%2C%20and%201-2%25%20of%20patients%20with%20primary%20brain%20tumors.&f=false. Accessed on January 19, 2016
  3. ↑ "Neoplastic Meningitis".


Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Neoplastic_meningitis_epidemiology_and_demographics&oldid=1579881"